US 10654916
Compositions and methods for the treatment of neuromyelitis optica
granted A61KA61K39/3955A61K45/06
Quick answer
US patent 10654916 (Compositions and methods for the treatment of neuromyelitis optica) held by THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, A CALIFORNIA CORPORATION expires Mon May 14 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, A CALIFORNIA CORPORATION
- Grant date
- Tue May 19 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 14 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K39/3955, A61K45/06, A61P, A61P1/08